ArticlemAbs2015

A fully human monoclonal antibody with novel binding epitope and excellent neutralizing activity to multiple human IFN-α subtypes: A candidate therapy for systemic lupus erythematosus.

Peng Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.